Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.27
▾0.00 (0.00%)
Last trade: 30/05, 7:18AM
Market cap
$58.75m
Trading Suspended
Investor Presentations
Principal Activity
TBG Diagnostics Limited (TDL, formerly Progen Pharmaceuticals Limited) is a biotechnology company focused on the global molecular diagnostic industry and is involved in the development, manufacture and marketing of molecular diagnostic kits, instruments and services. The company's operating Segment includes � In Vitro Diagnostics. Former Names Progen Industries Limited (PGL), 02/04/2007; Progen Pharmaceuticals Limited (PGL), 02/02/2016
Address
Level 18/101 Collins St, Melbourne VIC 3000, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.27
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia